The price of innovation - the role of drug pricing in financing pharmaceutical innovation. A conceptual framework
The debate on drug prices has reached new heights with the controversy around the role of prices in promoting innovation. Critics claim that prices of innovative drugs are excessive and argue that lowering prices will not harm the flourishing innovation. On the opposite end, the pharmaceutical indus...
I tiakina i:
Ngā kaituhi matua: | Santiago G. Moreno (Author), David Epstein (Author) |
---|---|
Hōputu: | Pukapuka |
I whakaputaina: |
Taylor & Francis Group,
2019-01-01T00:00:00Z.
|
Ngā marau: | |
Urunga tuihono: | Connect to this object online. |
Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Ngā tūemi rite
-
Pricing of Consumer Innovations
mā: Ebbing, Tobias
I whakaputaina: (2022) -
Pricing of Consumer Innovations
mā: Ebbing, Tobias
I whakaputaina: (2022) -
Pricing of Consumer Innovations
mā: Ebbing, Tobias
I whakaputaina: (2022) -
Medicines pricing and reimbursement: innovation, competitiveness, and access
mā: Adriana M. IVAMA-BRUMMELL, me ētahi atu.
I whakaputaina: (2022) -
Balancing medical innovation and affordability in the new healthcare ecosystem in China: Review of pharmaceutical pricing and reimbursement policies
mā: Vivian Chen, me ētahi atu.
I whakaputaina: (2023)